Replies to post #209760 on Biotech Values

[GrthzGd]

Ms. Grais' announcement about seeing the phase 2b data in a new light may have been worth an increase, but not to the pre Phase 2b level IMO, as they still need to redesign the Phase 3 trial so that it works this time.